Measurable residual disease recurrence as early warning of relapse in acute myeloid leukemia
To investigate the clinical features and outcomes of measurable residual disease recurrence (MRD-R) by multiparameter flow cytometric in acute myeloid leukemia (AML). We retrospectively analyzed clinical characteristic, residual disease status and outcomes of 767 newly diagnosed AML patients achiev...
Saved in:
| Main Authors: | Benfa Gong, Miao Yang, Shaowei Qiu, Bingcheng Liu, Ying Wang, Yingchang Mi, Hui Wei, Jianxiang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12103 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics and therapeutic determinants of <i>RUNX1::RUNX1T1</i> differ from those of <i>CBFB::MYH11</i> acute myeloid leukemia
by: Miao Yang, et al.
Published: (2025-04-01) -
Prognostic impact of co-mutations in adults with IDH1/2-mutated acute myeloid leukemia
by: Anli Lai, et al.
Published: (2025-06-01) -
KMT2C/D mutations in newly diagnosed acute myeloid leukaemia: Clinical features, genetic co‐occurrences and prognostic significance
by: Wenting Wang, et al.
Published: (2025-04-01) -
Treatment of pediatric relapsed and refractory acute myeloid leukemia
by: F. A. Makhacheva, et al.
Published: (2023-05-01) -
Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention
by: Aniket Bankar
Published: (2025-07-01)